Deerfield Mgmt HIF, L.P.
Insider CIK 1665736 · LRMR Director, 10% owner · GRAY 10% owner · EDIT 10% owner · PBLS 10% owner · FIXX Director, 10% owner · ONCR Director, 10% owner · PHGE Director, 10% owner · MIRM 10% owner · NUVL Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 43,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 43,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 2,717,627 | $124.00 | $336.99M | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 2,717,627 | $124.00 | $336.99M | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 3,789 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 3,789 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 4,147 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 4,147 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-17 | 8,299,225 | $124.00 | $1.03B | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-17 | 8,299,225 | $124.00 | $1.03B | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-17 | 650,000 | $124.00 | $80.60M | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | U Tender | 2026-07-15 | 2026-07-17 | 5,146 | $124.00 | $638.1K | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-17 | 3,444 | $124.00 | $427.1K | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | U Tender | 2026-07-15 | 2026-07-17 | 5,146 | $124.00 | $638.1K | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 246,732 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 246,732 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 464,550 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 464,550 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 143,650 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 166,070 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 166,070 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-11 | 143,650 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 149,238 | — | $0 | 272,228 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 122,990 | — | $0 | 122,990 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 122,990 | — | $0 | 122,990 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 149,238 | — | $0 | 272,228 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 260,992 | — | $0 | 533,220 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 260,992 | — | $0 | 533,220 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 407,132 | — | $0 | 940,352 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-11 | 407,132 | — | $0 | 940,352 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 1,084,012 | $5.00 | $5.42M | 10,622,957 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 831,978 | $5.00 | $4.16M | 8,153,107 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 2,000,000 | $5.00 | $10.00M | 6,207,982 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 1,084,010 | $5.00 | $5.42M | 10,622,928 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2025-11-24 | 2025-11-24 | 371,287 | $95.45 | $35.44M | 8,299,225 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2025-11-24 | 2025-11-24 | 371,287 | $95.45 | $35.44M | 8,299,225 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 2,599,932 | $3.20 | $8.32M | 7,321,129 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 3,387,539 | $3.20 | $10.84M | 9,538,945 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2025-07-31 | 2025-08-04 | 3,387,529 | $3.20 | $10.84M | 9,538,918 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-04-21 | 2025-04-23 | 1,611,864 | — | $0 | 1,611,864 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-04-21 | 2025-04-23 | 1,611,864 | — | $0 | 1,611,864 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 1,258,614 | — | $0 | 1,258,614 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 1,258,614 | — | $0 | 1,258,614 | SEC↗ |
| PHGE BiomX Inc. | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,611,863 | — | $0 | 405,637 | SEC↗ |
| PHGE BiomX Inc. | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,611,863 | — | $0 | 405,637 | SEC↗ |
| PHGE BiomX Inc. | M Exercise | 2025-02-27 | 2025-03-03 | 353,249 | $0.93 | $328.5K | 1,247,054 | SEC↗ |
| PHGE BiomX Inc. | M Exercise | 2025-02-27 | 2025-03-03 | 353,249 | $0.93 | $328.5K | 1,247,054 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2024-10-22 | 2024-10-24 | 1,000,000 | $97.75 | $97.75M | 8,670,512 | SEC↗ |
| NUVL Nuvalent, Inc. | S Sale | 2024-10-22 | 2024-10-24 | 1,000,000 | $97.75 | $97.75M | 8,670,512 | SEC↗ |
| PHGE BiomX Inc. | M Exercise deriv | 2024-07-15 | 2024-07-17 | 5,883 | — | $0 | 47,957 | SEC↗ |
| PHGE BiomX Inc. | M Exercise deriv | 2024-07-15 | 2024-07-17 | 5,883 | — | $0 | 47,957 | SEC↗ |
| PHGE BiomX Inc. | M Exercise | 2024-07-15 | 2024-07-17 | 5,883,000 | — | $0 | 8,938,049 | SEC↗ |
| PHGE BiomX Inc. | M Exercise | 2024-07-15 | 2024-07-17 | 5,883,000 | — | $0 | 8,938,049 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-09 | 2024-07-11 | 20,175,000 | — | $0 | 20,175,000 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-09 | 2024-07-11 | 20,175,000 | — | $0 | 20,175,000 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-09 | 2024-07-11 | 722,175 | — | $0 | 722,175 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-07-09 | 2024-07-11 | 722,175 | — | $0 | 722,175 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 13,490 | — | $0 | 13,490 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 40,350 | — | $0 | 53,840 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 40,350 | — | $0 | 53,840 | SEC↗ |
| PHGE BiomX Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 13,490 | — | $0 | 13,490 | SEC↗ |
| PHGE BiomX Inc. | A Award | 2024-03-15 | 2024-03-19 | 3,055,049 | — | $0 | 3,055,049 | SEC↗ |
| PHGE BiomX Inc. | A Award | 2024-03-15 | 2024-03-19 | 3,055,049 | — | $0 | 3,055,049 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,205 | $8.74 | $12.50M | 4,207,982 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,206 | $8.74 | $12.50M | 6,151,389 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-02-16 | 1,430,206 | $8.74 | $12.50M | 6,151,406 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 15,220 | $0.27 | $4.1K | 284,697 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 61,826 | $0.27 | $16.7K | 1,156,309 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-30 | 2022-12-30 | 61,826 | $0.27 | $16.7K | 1,156,308 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 63,107 | $0.26 | $16.4K | 1,218,135 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 63,108 | $0.26 | $16.4K | 1,218,134 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-29 | 2022-12-30 | 15,538 | $0.26 | $4.0K | 299,917 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 24,757 | $0.25 | $6.2K | 1,281,242 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 6,096 | $0.25 | $1.5K | 315,455 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-28 | 2022-12-30 | 24,757 | $0.25 | $6.2K | 1,281,242 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 7,136 | $0.27 | $1.9K | 321,551 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 28,977 | $0.27 | $7.8K | 1,305,999 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-27 | 2022-12-27 | 28,977 | $0.27 | $7.8K | 1,305,999 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 3,693 | $0.28 | $1.0K | 1,334,976 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 3,692 | $0.28 | $1.0K | 1,334,976 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-22 | 2022-12-27 | 909 | $0.28 | $255 | 328,687 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 6,144 | $0.30 | $1.8K | 1,338,668 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 6,143 | $0.30 | $1.8K | 1,338,669 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-21 | 2022-12-21 | 1,513 | $0.30 | $454 | 329,596 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 1,616 | $0.31 | $501 | 331,109 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 6,562 | $0.31 | $2.0K | 1,344,812 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-20 | 2022-12-21 | 6,562 | $0.31 | $2.0K | 1,344,812 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 44,394 | $0.29 | $12.9K | 1,351,374 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 44,394 | $0.29 | $12.9K | 1,351,374 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-19 | 2022-12-21 | 10,930 | $0.29 | $3.2K | 332,725 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 1,375 | $0.39 | $536 | 1,395,768 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 339 | $0.39 | $132 | 343,655 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-15 | 2022-12-15 | 1,375 | $0.39 | $536 | 1,395,768 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 943 | $0.38 | $358 | 343,994 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 3,829 | $0.38 | $1.5K | 1,397,143 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-14 | 2022-12-15 | 3,828 | $0.38 | $1.5K | 1,397,143 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 934 | $0.41 | $383 | 1,400,971 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 933 | $0.41 | $383 | 1,400,972 | SEC↗ |
| ONCR Oncorus, Inc. | S Sale | 2022-12-13 | 2022-12-15 | 230 | $0.41 | $94 | 344,937 | SEC↗ |
| NUVL Nuvalent, Inc. | P Buy | 2022-11-03 | 2022-11-07 | 650,000 | $33.50 | $21.77M | 650,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 2,777,777 | $3.15 | $8.75M | 2,777,777 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 2,777,777 | $3.15 | $8.75M | 4,721,197 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 2,777,777 | $3.15 | $8.75M | 4,721,183 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 2,777,777 | $3.15 | $8.75M | 4,721,200 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2022-06-06 | 2022-06-08 | 171 | $25.08 | $4.3K | 1,711,153 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2022-06-06 | 2022-06-08 | 6,909 | $24.47 | $169.1K | 1,704,244 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2022-06-06 | 2022-06-08 | 155 | $25.08 | $3.9K | 1,546,433 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2022-06-06 | 2022-06-08 | 6,243 | $24.47 | $152.8K | 1,540,190 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2022-06-06 | 2022-06-08 | 11,868 | $25.29 | $300.1K | 1,546,588 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2022-06-06 | 2022-06-08 | 13,132 | $25.29 | $332.1K | 1,711,324 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 4,831,384 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 45,716,568 | — | $0 | 13,011,988 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 45,716,568 | — | $0 | 13,011,988 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 13,011,988 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 13,011,988 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 4,831,384 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 2,417,628 | — | $0 | 2,417,628 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 2,417,628 | — | $0 | 2,417,628 | SEC↗ |
| NUVL Nuvalent, Inc. | P Buy deriv | 2021-08-02 | 2021-08-04 | 300,000 | $17.00 | $5.10M | 2,717,628 | SEC↗ |
| NUVL Nuvalent, Inc. | P Buy deriv | 2021-08-02 | 2021-08-04 | 300,000 | $17.00 | $5.10M | 2,717,628 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion | 2021-08-02 | 2021-08-04 | 8,494,140 | — | $0 | 8,772,840 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion | 2021-08-02 | 2021-08-04 | 8,494,140 | — | $0 | 8,772,840 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion | 2021-08-02 | 2021-08-04 | 897,671 | — | $0 | 9,670,511 | SEC↗ |
| NUVL Nuvalent, Inc. | C Conversion | 2021-08-02 | 2021-08-04 | 897,671 | — | $0 | 9,670,511 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-07-09 | 2021-07-13 | 99,325 | $15.81 | $1.57M | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-07-07 | 2021-07-07 | 6,837 | $15.87 | $108.5K | 99,325 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-07-06 | 2021-07-07 | 49,239 | $16.20 | $797.7K | 106,162 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-07-02 | 2021-07-07 | 10,599 | $17.01 | $180.3K | 155,401 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2021-06-30 | 2021-07-02 | 228,571 | $8.75 | $2.00M | 1,943,423 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2021-06-30 | 2021-07-02 | 228,569 | $8.75 | $2.00M | 1,943,406 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2021-06-30 | 2021-07-02 | 228,570 | $8.75 | $2.00M | 1,943,420 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 32,884 | $19.00 | $624.8K | 345,167 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 133,558 | $19.00 | $2.54M | 1,401,905 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 133,558 | $19.00 | $2.54M | 1,401,905 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 7,499,999 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 7,499,999 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 823,150 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 445,194 | $15.00 | $6.68M | 1,268,344 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 445,194 | $15.00 | $6.68M | 1,268,344 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 202,670 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 109,612 | $15.00 | $1.64M | 312,282 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 823,150 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 620,480 | — | $0 | 620,480 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 620,480 | — | $0 | 620,480 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 12,809,912 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 12,809,910 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion deriv | 2020-09-29 | 2020-10-01 | 2,624,901 | — | $0 | 0 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 291,467 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 1,713,873 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | P Buy | 2020-09-29 | 2020-10-01 | 1,562,500 | $16.00 | $25.00M | 1,853,967 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 1,422,406 | — | $0 | 1,422,406 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 1,422,406 | — | $0 | 1,422,406 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | C Conversion | 2020-09-29 | 2020-10-01 | 291,467 | — | $0 | 1,713,873 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-30 | 2020-01-31 | 509,970 | $15.45 | $7.88M | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-29 | 2020-01-31 | 8,857 | $15.45 | $136.8K | 509,970 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-28 | 2020-01-28 | 65,891 | $15.51 | $1.02M | 518,827 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-27 | 2020-01-28 | 193,359 | $15.77 | $3.05M | 584,718 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2020-01-24 | 2020-01-28 | 380,256 | $15.69 | $5.97M | 778,077 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-24 | 2019-12-27 | 198,767 | $21.95 | $4.36M | 2,321,199 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-24 | 2019-12-27 | 151,233 | $21.95 | $3.32M | 1,766,106 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-23 | 2019-12-23 | 56,595 | $21.83 | $1.24M | 1,917,339 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-23 | 2019-12-23 | 74,384 | $21.83 | $1.62M | 2,519,966 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-20 | 2019-12-23 | 9,130 | $21.50 | $196.3K | 1,973,934 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-20 | 2019-12-23 | 11,999 | $21.50 | $258.0K | 2,594,350 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-19 | 2019-12-23 | 5,454 | $21.68 | $118.2K | 1,983,064 | SEC↗ |
| FIXX Homology Medicines, Inc. | S Sale | 2019-12-19 | 2019-12-23 | 7,168 | $21.68 | $155.4K | 2,606,349 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 12,467,650 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 12,467,650 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 1,558,456 | — | $0 | 1,558,456 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 1,558,456 | — | $0 | 1,558,456 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 166,000 | $15.00 | $2.49M | 1,724,456 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 166,000 | $15.00 | $2.49M | 166,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2019-04-12 | 2019-04-15 | 533,333 | $22.50 | $12.00M | 1,158,333 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 6,944,444 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 6,944,445 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 3,521,126 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 3,521,126 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 669,034 | — | $0 | 669,034 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2018-04-02 | 2018-04-04 | 625,000 | $16.00 | $10.00M | 625,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | P Buy | 2018-04-02 | 2018-04-04 | 625,000 | $16.00 | $10.00M | 2,613,517 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 669,034 | — | $0 | 669,034 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 1,319,483 | — | $0 | 1,988,517 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 1,319,484 | — | $0 | 1,988,518 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 854,700 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 854,700 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2016-02-08 | 2016-02-08 | 100,000 | $16.00 | $1.60M | 954,700 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-08 | 854,700 | — | $0 | 854,700 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-08 | 854,700 | — | $0 | 854,700 | SEC↗ |